封面
市場調查報告書
商品編碼
1586739

影像導引治療全球市場,2024-2029

Image-guided Therapy Market, Global, 2024-2029

出版日期: | 出版商: Frost & Sullivan | 英文 107 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

對微創手術的需求不斷成長以及門診設施日間手術的激增推動了變革性成長

影像引導治療(IGT)市場主要由對微創治療的偏好、多模態成像診斷、人工智慧、軟體解決方案的使用實現更好的臨床結果以及癌症治療的精確度的不斷成長所推動。保健的高需求。此外,IGT 市場也受到腫瘤學、心臟病學、神經外科、整形外科和泌尿系統手術中 MRI、CT、分子影像、超音波和介入性 X 光技術創新的影響。上述醫學影像模式與導航系統和機器人技術的整合使得外科手術具有更高的精確度和準確度。

Frost & Sullivan 預測,在研發支出和投資增加的推動下,IGT 將在未來五年保持穩定成長,推動市場擴張。此外,Frost & Sullivan預測微創手術將比傳統手術具有更高的滲透率,推動IGT市場的成長。

研究期間為2022年至2029年,基準年為2024年,預測期間為2025年至2029年。本研究分析了北美、歐洲、亞太地區和世界其他地區的市場,重點關注當前情況、驅動和限制因素、新興技術和值得注意的參與企業。

Frost & Sullivan 將 IGT 市場分為以下幾類: - 產品類型:資本設備 -醫療設備和消耗品 - 解決方案 - 臨床應用:腫瘤學、心臟病學、神經外科、泌尿系統、骨科手術

目錄

成長機會分析

  • 分析範圍
  • 區隔

IGT 市場的轉型

  • 為什麼成長越來越困難?
  • The Strategic Imperative 8(TM)
  • 三大策略對IGT產業的影響

IGT 市場的生態系統

  • 定義
  • IGT 作為跨模態融合
  • 治療方式的影像引導
  • 主要 IGT 解決方案
  • IGT服務供應商的類型
  • 臨床應用領域的發展
  • 競爭環境
  • 主要競爭對手

成長要素

  • 成長指標
  • 生長促進因子
  • 成長抑制因素
  • 預測考慮因素
  • 收益預測
  • 依產品類型分類的收益預測
  • 地區收益預測
  • 臨床應用收益預測
  • 收益分析
  • 收益佔有率
  • 收益佔有率分析

成長動力:北美

  • 成長指標
  • 收益預測
  • 依產品類型分類的收益預測
  • 臨床應用收益預測
  • 預測分析
  • 輻射解決方案(包括 IGT 解決方案)的聯邦法規
  • 競品分析

成長動力:歐洲

  • 成長指標
  • 收益預測
  • 依產品類型分類的收益預測
  • 臨床應用收益預測
  • 預測分析
  • 適用於放射學解決方案(包括 IGT 解決方案)的一般資料保護規範(GDPR)
  • 競品分析

成長動力:亞太地區

  • 成長指標
  • 收益預測
  • 依產品類型分類的收益預測
  • 臨床應用收益預測
  • 預測分析
  • 醫療旅遊是 IGT 市場的機會
  • 競品分析

成長動力:其他區域市場

  • 成長指標
  • 收益預測
  • 依產品類型分類的收益預測
  • 臨床應用收益預測
  • 預測分析
  • 競品分析

臨床應用概述:應用重點-癌症領域

  • 癌症治療選擇
  • 器官特異性影像導航放射治療及放射線手術
  • 放射治療 - 概述
  • 影像導引近距離放射治療(IGBT)- 概述
  • 術中近距離放射治療(IOBT)程序
  • 公司聚焦:Elekta 的腫瘤學產品

臨床應用概述:應用重點-心臟病學

  • 心臟病的主要治療選擇
  • IXR Suite 在心臟病學中的使用
  • X 光引導 IVUS 程式
  • 公司聚焦:Boston Scientific Corporation的心臟病產品

臨床應用概述:應用重點 - 神經病學

  • 神經系統治療選擇
  • 神經病學治療藍圖
  • 公司聚焦:Koninklijke Philips NV 的Neurobiplane 介入系統

臨床應用概述:應用重點-泌尿系統

  • IGT--泌尿系統干預
  • 公司聚焦:GE 醫療保健「bkActiv」泌尿系統產品

臨床應用概述:應用重點 -整形外科

  • IGT-整形外科干預
  • 公司聚焦:Ziehm Imaging GmbH 的整形外科產品

成長機會宇宙

  • 成長機會1:影像導引治療的真實資料
  • 成長機會2:影像引導高強度聚焦在多模態成像的應用
  • 成長機會3:亞太地區的微創手術
  • 成長機會4:整合雲端基礎平台和人工智慧解決方案來管理大量手術資料

附錄與後續步驟

  • 成長機會的好處和影響
  • 下一步
  • 圖表列表
  • 免責聲明
簡介目錄
Product Code: PFOJ-50

Increased Demand for Minimally Invasive Procedures and the Surge in Day Surgeries at Outpatient Facilities are Driving Transformational Growth

The image-guided therapy (IGT) market is growing rapidly, mainly driven by the rising preference for minimally invasive procedures, technological advancements in multimodal imaging, artificial intelligence, the use of software solutions that enable better clinical outcomes, and the high demand for precision medicine in oncology treatment. In addition, the IGT market is influenced by technological innovations in MRI, CT, molecular imaging, ultrasound, and interventional X-ray during oncology, cardiology, neurosurgery, orthopedic, and urology procedures. The integration of the aforementioned medical imaging modalities with navigation systems and robotics has enabled higher precision and accuracy during surgical procedures.

Frost & Sullivan expects IGT to sustain steady growth during the next 5 years, fueled by increasing expenditures and investments in research and development that drive market expansion. Frost & Sullivan also expects minimally invasive procedures to see higher adoption than conventional surgical procedures, which will propel IGT market growth.

The study period is from 2022 to 2029, the base year is 2024, and the forecast period is from 2025 to 2029. The study analyzes the North American, European, Asia-Pacific, and Rest of World markets, focusing on current scenarios, drivers and restraints, the latest technologies, and notable participants.

Frost & Sullivan segments the IGT market into the following categories: - Product type: - Capital equipment - Medical devices and consumables - Solutions - Clinical applications: oncology, cardiology, neurosurgery, urology, and orthopedics

Table of Contents

Growth Opportunity Analysis

  • Scope of Analysis
  • Segmentation

Transformation in the IGT Market

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the IGT Industry

Ecosystem in the IGT Market

  • Definition
  • IGT as a Cross-modality Convergence
  • Image Guidance by Therapeutic Modalities
  • Key IGT Solutions
  • IGT Service Provider Types
  • Developments in Clinical Application Areas
  • Competitive Environment
  • Key Competitors

Growth Generator

  • Growth Metrics
  • Growth Drivers
  • Growth Restraints
  • Forecast Considerations
  • Revenue Forecast
  • Revenue Forecast by Product Type
  • Revenue Forecast by Region
  • Revenue Forecast by Clinical Applications
  • Revenue Forecast Analysis
  • Revenue Share
  • Revenue Share Analysis

Growth Generator: North America

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Product Type
  • Revenue Forecast by Clinical Applications
  • Forecast Analysis
  • Federal Regulations for Radiology Solutions, Including IGT Solutions
  • Competitive Analysis

Growth Generator: Europe

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Product Type
  • Revenue Forecast by Clinical Applications
  • Forecast Analysis
  • GDPR for Radiology Solutions, Including IGT Solutions
  • Competitive Analysis

Growth Generator: APAC

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Product Type
  • Revenue Forecast by Clinical Applications
  • Forecast Analysis
  • Medical Tourism as an Opportunity for the IGT Market
  • Competitive Analysis

Growth Generator: RoW

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Product Type
  • Revenue Forecast by Clinical Applications
  • Forecast Analysis
  • Competitive Analysis

Overview of Clinical Applications: Application Focus-Oncology

  • Treatment Options for Oncology
  • Organ-specific Image-guided Radiotherapy andRadiosurgery
  • Radiation Therapy-Overview
  • Image-guided Brachytherapy (IGBT)-Overview
  • Intraoperative Brachytherapy (IOBT) Procedures
  • Company Spotlight: Elekta's Offerings for Oncology

Overview of Clinical Applications: Application Focus-Cardiology

  • Major Treatment Options for Cardiology
  • Use of IXR Suites in Cardiology
  • X-ray-guided IVUS Procedures
  • Company Spotlight: Boston Scientific Corporation's Offerings for Cardiology

Overview of Clinical Applications: Application Focus-Neurology

  • Treatment Options for Neurology
  • Roadmaps for Neurology Treatment
  • Company Spotlight: Koninklijke Philips N.V.'s Neuro Biplane Interventional System

Overview of Clinical Applications: Application Focus-Urology

  • IGT-Urology Interventions
  • Company Spotlight: GE HealthCare 's bkActiv for Urology Intervention

Overview of Clinical Applications: Application Focus-Orthopedics

  • IGT-Orthopedic Interventions
  • Company Spotlight: Ziehm Imaging GmbH's Offerings for Orthopedic Interventions

Growth Opportunity Universe

  • Growth Opportunity 1: Real-world Data for Image-guided Therapy
  • Growth Opportunity 2: Using Image-guided High-intensity Focused Ultrasound in Multimodal Imaging
  • Growth Opportunity 3: Minimally Invasive Procedures in APAC
  • Growth Opportunity 4: Integration of AI-based Solutions with Cloud-based Platforms to Manage Large Volumes of Surgical Data

Appendix & Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • List of Exhibits
  • Legal Disclaimer